High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: A preliminary report

Kim, 1989, Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stages IB and II with bulky tumor, Gynecol. Oncol., 33, 225, 10.1016/0090-8258(89)90557-X Sardi, 1988, Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix utery, Gynecol. Oncol., 31, 256, 10.1016/S0090-8258(88)80002-7 Weiner, 1988, A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma, Gynecol. Oncol., 30, 1, 10.1016/0090-8258(88)90038-8 Kirsten, 1987, Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer, Br. J. Obstet., 94, 583, 10.1111/j.1471-0528.1987.tb03154.x Friedlander, 1984, The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study, Gynecol. Oncol., 19, 1, 10.1016/0090-8258(84)90150-1 Benedetti Panici, 1988, Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: A pilot study, Obstet. Gynecol., 71, 344 Benedetti Panici, 1991, Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer: Prognostic factors for response and survival, Cancer, 67, 372, 10.1002/1097-0142(19910115)67:2<372::AID-CNCR2820670210>3.0.CO;2-5 Benedetti Panici, 1987, Squamous cervical cancer at stage IB and II: A ten years experience, analysis of 231 cases, Eur. J. Gynaecol. Oncol., 8, 76 Di Saia, 1987, Phase III study on the treatment of women with cervical cancer stage IIB, IIIB and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corinebacterium parvum: A Gynecologic Oncology Group Study, Gynecol. Oncol., 26, 386, 10.1016/0090-8258(87)90031-X Montana, 1985, Analysis of results of radiation therapy for stage II carcionoma of the cervix, Cancer, 55, 956, 10.1002/1097-0142(19850301)55:5<956::AID-CNCR2820550507>3.0.CO;2-V Montana, 1986, Carcinoma of the cervix, stage III results of radiation therapy, Cancer, 57, 148, 10.1002/1097-0142(19860101)57:1<148::AID-CNCR2820570130>3.0.CO;2-7 Utley, 1984, High-dose rate after loading brachytherapy in carcinoma of the uterine cervix, Int. J. Radiat. Oncol. Biol. Phys., 10, 2259, 10.1016/0360-3016(84)90231-1 Thigpen, 1979, cis-Dichlorodiammineplatinum (II) in the treatment of gynecologic malignancies: Phase II trials by the Gynecologic Oncology Group, Cancer Treat. Rep., 63, 1549 Thigpen, 1986, Cisplatin in the management of patients with advanced or recurrent squamous carcinoma of the cervix: Effects of prolonged infusion, 5, 116 Ozols, 1984, High dose cisplatin in hypertonic saline, Ann. Intern. Med., 100, 19, 10.7326/0003-4819-100-1-19 Behrens, 1985, Cytoxicity of 3 cisplatin analogues in a drug sensitive and a new cisplatin resistant human ovarian cancer cell line, 26, 262 Bruckner, 1981, High-dose cisplatin for refractory ovarian cancer, Gynecol. Oncol., 12, 64, 10.1016/0090-8258(81)90095-0 Baker, 1981, Use of high dose cis-dichlorodiammineplatinum (II) following failure of previous chemotherapy for advanced carcinoma of the ovary, Br. J. Obstet. Gynaecol., 88, 1192, 10.1111/j.1471-0528.1981.tb01196.x Zunino, 1989, Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug, Chem. Biol. Iteract., 70, 89, 10.1016/0009-2797(89)90065-3 Di Re, 1990, Efficacy and safety of high-dose cisplatin and cyclophosfamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer, Cancer Chemother. Pharmacol., 25, 355, 10.1007/BF00686237 Ozols, 1984, Chemotherapy of ovarian cancer, Semin. Oncol., 11, 251 1988, Vol. 20 World Health Organization, 1979 Piver, 1974, Five classes of extended hysterectomy for women with cervical cancer, Obstet. Gynecol., 44, 264 Kim, 1985, Primary chemotherapy and postoperative adjuvant chemotherapy in the treatment of squamous cell carcinoma of the uterine cervix, Gynecol. Oncol., 22, 59, 10.1016/0090-8258(85)90008-3 Dargent, 1985, V factor (tumor volume) and T factor (FIGO classification) in the assessment of cervix cancer prognosis: The risk of lymph node spread, Gynecol. Oncol., 22, 15, 10.1016/0090-8258(85)90002-2 Rustin, 1987, Cisplatin, vincristine, methotrexate, and bleomycin (POMB) as initial or palliative therapy for carcinoma of the cervix, Br. J. Obstet. Gynaecol., 94, 1205, 10.1111/j.1471-0528.1987.tb02323.x Symonds, 1989, The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of the cervix, Br. J. Cancer, 59, 473, 10.1038/bjc.1989.98 Murray, 1987, The importance of dose and dose intensity in lung cancer chemotherapy, Semin. Oncol. Suppl., 14, 20 Hryniuk, 1987, Applications of dose-intensity to problems in chemotherapy of breast and colorectal cancer, Semin. Oncol. Suppl., 14, 3 Ozols, 1988, A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors, J. Clin. Oncol., 6, 1031, 10.1200/JCO.1988.6.6.1031 McVie, 1984, The role of pharmacokinetics in (combination) chemotherapy, Cancer Suppl., 54, 1175, 10.1002/1097-0142(19840915)54:1+<1175::AID-CNCR2820541314>3.0.CO;2-3 Powis, 1983, Dose dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in man, Drug. Metab. Rev., 14, 1145, 10.3109/03602538308991425 Moore, 1987, Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy, Clin. Pharmacokinet., 13, 205, 10.2165/00003088-198713040-00001